These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 7537538

  • 1. Involvement of CD5 in Th1 and Th2 contact-mediated rescue of anti-mu and ionomycin induced growth inhibition in a B cell lymphoma.
    Muthukkumar S, Bondada S.
    Int Immunol; 1995 Feb; 7(2):305-15. PubMed ID: 7537538
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Polyclonal activation of immature B cells by preactivated T cells: the role of IL-4 and CD40 ligand.
    Brines RD, Klaus GG.
    Int Immunol; 1993 Nov; 5(11):1445-50. PubMed ID: 7505108
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A role for CD5 in cognate interactions between T cells and B cells, and identification of a novel ligand for CD5.
    Bikah G, Lynd FM, Aruffo AA, Ledbetter JA, Bondada S.
    Int Immunol; 1998 Aug; 10(8):1185-96. PubMed ID: 9723705
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Co-stimulation by anti-immunoglobulin is required for B cell activation by CD40Llow T cells.
    Poudrier J, Owens T.
    Eur J Immunol; 1994 Dec; 24(12):2993-9. PubMed ID: 7805727
    [Abstract] [Full Text] [Related]

  • 9. Helper effector function of human T cells stimulated by anti-CD3 mAb can be enhanced by co-stimulatory signals and is partially dependent on CD40-CD40 ligand interaction.
    Kwekkeboom J, de Rijk D, Kasran A, Barcy S, de Groot C, de Boer M.
    Eur J Immunol; 1994 Mar; 24(3):508-17. PubMed ID: 7510232
    [Abstract] [Full Text] [Related]

  • 10. The effects of IFN-gamma on CD40-mediated activation of B cells from X-linked immunodeficient or normal mice.
    Johnson-Léger C, Hasbold J, Holman M, Klaus GG.
    J Immunol; 1997 Aug 01; 159(3):1150-9. PubMed ID: 9233608
    [Abstract] [Full Text] [Related]

  • 11. Antibodies to murine CD40 protect normal and malignant B cells from induced growth arrest.
    Santos-Argumedo L, Gordon J, Heath AW, Howard M.
    Cell Immunol; 1994 Jul 01; 156(2):272-85. PubMed ID: 7517793
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Strength of TCR signal determines the costimulatory requirements for Th1 and Th2 CD4+ T cell differentiation.
    Tao X, Constant S, Jorritsma P, Bottomly K.
    J Immunol; 1997 Dec 15; 159(12):5956-63. PubMed ID: 9550393
    [Abstract] [Full Text] [Related]

  • 16. Ligation of CD40 with soluble CD40 ligand reverses anti-immunoglobulin-mediated negative signalling in murine B lymphoma cell lines but not in immature B cells from neonatal mice.
    Marshall-Clarke S, Owen G, Tasker L.
    Immunology; 1996 Apr 15; 87(4):624-32. PubMed ID: 8675219
    [Abstract] [Full Text] [Related]

  • 17. Lymphoma models for B cell activation and tolerance. V. Anti-Ig mediated growth inhibition is reversed by phorbol myristate acetate but does not involve changes in cytosolic free calcium.
    Scott DW, Livnat D, Whitin J, Dillon SB, Snyderman R, Pennell CA.
    J Mol Cell Immunol; 1987 Apr 15; 3(2):109-20. PubMed ID: 3509921
    [Abstract] [Full Text] [Related]

  • 18. The synergistic effects of anti-IgM and monoclonal anti-Ia antibodies in induction of murine B lymphocyte activation.
    Baluyut AR, Subbarao B.
    J Mol Cell Immunol; 1988 Apr 15; 4(1):45-57. PubMed ID: 3266924
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. T-BAM/CD40-L on helper T lymphocytes augments lymphokine-induced B cell Ig isotype switch recombination and rescues B cells from programmed cell death.
    Lederman S, Yellin MJ, Cleary AM, Pernis A, Inghirami G, Cohn LE, Covey LR, Lee JJ, Rothman P, Chess L.
    J Immunol; 1994 Mar 01; 152(5):2163-71. PubMed ID: 7907632
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.